Dec 11, 2024
RapidPulse Receives FDA Approval to Begin IDE Study in Ischemic Stroke Using Innovative Cyclic Aspiration System – Recently Completed Clinical Trial Shows Significantly Higher First Pass and Frontline Success Rates
Read More
Dec 6, 2024
Alveron Pharma Announces Close of €5M Seed Extension Financing, led by Broadview Ventures, to Accelerate Breakthrough Therapy for Intracranial Haemorrhage
Read More
Dec 4, 2024
Antag Therapeutics Announces €80 Million Series A Financing
Read More
Dec 2, 2024
XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio
Read More
Nov 20, 2024
Results from Cardiosense’s SEISMIC-HF I Study of a Machine Learning Model to Non-Invasively Assess Cardiac Filling Pressure Presented as Late-Breaking Science at American Heart Association’s 2024 Scientific Sessions
Read More
Oct 24, 2024
CroíValve Announces First Implant of a Novel Minimally Invasive Device for Tricuspid Regurgitation in US Early Feasibility Study
Read More
1234567